COOPER COMPANIES, INC.
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
Cooper Companies director Walter M. Rosebrough Jr. bought 10,000 shares of common stock on September 11 and 14, 2026, at average prices of $54.11 and $54.29 per share. The purchases were made indirectly through a revocable trust and were not part of a preset trading plan.
Rosebrough Walter M Jr purchased 10,000 indirectly-held shares of COOPER COMPANIES, INC. (COO) at an average of $54.16 ($54.11–$54.29, $0.54M total) across 2 trades over 2026-09-11 to 2026-09-14.
Cooper Companies (COO) director Lawrence Erik Kurzius bought 10,000 shares of common stock on September 14, 2026, at $53.915 per share, totaling $539,000. He now directly holds 21,099 shares. The purchase was not part of a Rule 10b5-1 trading plan.
Over the past 7 days, AlphAI's AI scored 25 news stories mentioning COO (COOPER COMPANIES, INC.). Coverage has skewed bearish: 2 bullish, 3 neutral, and 20 bearish.
Recent COO coverage spans financial news, insider activity and earnings.
In the last 30 days, COO insiders filed 4 SEC Form 4 transactions — 4 purchases ($1.3M) and no sales. The most active reporter was Rosebrough Walter M Jr with 2 filings.
Modest insider buying suggests slight confidence but limited price impact.
Small insider purchase may signal confidence but limited material impact.
The insider purchase signals confidence from management but the size ($539K) is modest, likely causing limited short-term price impact.
Insider buying suggests confidence, modest bullish pressure.
Small insider purchase likely signals confidence but size is modest relative to market cap.
AlphAI scores every news story that mentions COO with an AI model for sentiment and relevance, and aggregates insider trades from COOPER COMPANIES, INC.'s SEC EDGAR Form 4 filings. Figures refresh continuously.
Cooper Companies director Walter M. Rosebrough Jr. bought 10,000 shares of common stock on September 11 and 14, 2026, at average prices of $54.11 and $54.29 per share. The purchases were made indirectly through a revocable trust and were not part of a preset trading plan.
1 min readRosebrough Walter M Jr purchased 10,000 indirectly-held shares of COOPER COMPANIES, INC. (COO) at an average of $54.16 ($54.11–$54.29, $0.54M total) across 2 trades over 2026-09-11 to 2026-09-14.
1 min readCooper Companies (COO) director Lawrence Erik Kurzius bought 10,000 shares of common stock on September 14, 2026, at $53.915 per share, totaling $539,000. He now directly holds 21,099 shares. The purchase was not part of a Rule 10b5-1 trading plan.
1 min readKurzius Lawrence Erik purchased 10,000 shares of COOPER COMPANIES, INC. (COO) at $53.92 ($0.54M total) on 2026-09-14.
1 min readKeel Paul A purchased 4,701 shares of COOPER COMPANIES, INC. (COO) at $53.18 ($0.25M total) on 2026-09-11.
1 min readThe Cooper Companies (COO) lowered its fiscal 2026 profit and revenue forecasts due to weaker-than-expected contact lens demand, with adjusted EPS now expected at $4.51–$4.55 and revenue at $4.23–$4.25 billion. Q3 revenue was $1.07 billion, missing estimates, though adjusted EPS beat at $1.15. The company cited U.S. channel inventory reductions as a key factor and decided to retain CooperSurgical.
3 min readU.S. markets ended lower amid rising Treasury yields and inflation data. Apple unveiled its $1,999 foldable iPhone Duo. Novartis shares fell 14% after a drug trial failure. Meta introduced its AI agent, Muse. Oracle shares jumped on strong earnings. Quantum computing stocks rallied on CHIPS Act funding. Adobe shares fell despite beating estimates. Skyworks Solutions rose 19% over the week. CooperCompanies fell on lowered guidance. Macy's reported stronger-than-expected Q2 results.
4 min readCooper Companies (COO) fell 14.67% after reporting Q3 revenue of $1.07B and Q4 guidance below estimates. Freeport-McMoRan (FCX) dropped 6.59% due to White House uncertainty on copper tariffs. Baker Hughes (BKR) declined 6.66% despite raising its full-year revenue guidance to $28.5B-$30.3B.
2 min readCooperCompanies reported Q2 revenue of $1.07B (flat YoY, 2.9% miss) and adjusted EPS of $1.15 (2.7% beat). Full-year guidance was lowered to $4.24B revenue and $4.53 EPS. The company reduced U.S. inventory and retained CooperSurgical after a strategic review. Management plans to invest in sales and R&D, aiming for future growth and improved margins.
2 min readThe Cooper Companies (COO) completed its strategic review, deciding not to sell CooperSurgical. The board cited temporary valuation impacts, including competition and litigation, for the decision. The company plans to focus on capital allocation, organic growth, and fertility sector expansion.
2 min read
